Systemic Lupus Erythematosus: Understanding, Symptoms, and Treatment

What are systemic autoimmune diseases?

Systemic autoimmune diseases are a group of chronic conditions in which the immune system mistakenly attacks the body's own tissues, causing inflammation and damage to various organs and systems. Systemic lupus erythematosus (SLE) is one of the most well-known examples of such diseases. It can affect joints, skin, kidneys, heart, lungs, blood vessels, and the brain. However, it is important to note that the presented scientific publications do not contain direct information about systemic lupus erythematosus. Instead, they describe other complex systemic conditions, such as systemic sclerosis, plasma cell leukemia, and Sturge-Weber syndrome, which also require a comprehensive approach to diagnosis and treatment.

Systemic sclerosis: an example of autoimmune involvement

Systemic sclerosis (SSc), or scleroderma, is another complex autoimmune disease characterized by vasculopathy (vascular damage), fibrosis (tissue thickening), and multisystem involvement [8]. This condition can manifest with diverse symptoms affecting the skin, gastrointestinal tract, lungs, and heart.

• Signs and symptoms: Patients with SSc may experience marked unintended weight loss, chronic abdominal pain after eating, bloating, vomiting, diarrhea, and loss of appetite [5]. External manifestations include wasting (cachexia), digital ulcers, generalized skin thickening with hyperpigmentation [5]. More severe forms may be accompanied by Raynaud's phenomenon, digital gangrene, skin calcinosis, extensive interstitial lung disease (ILD), severe pulmonary hypertension (PH), and right ventricular failure [8].
• Gastrointestinal involvement: The gastrointestinal tract is affected in up to 90% of SSc patients, but severe lower gastrointestinal motility disorders and intestinal pseudo-obstruction are less common, occurring in approximately 5.4% of patients [5].
• Diagnostics: Diagnosis of SSc includes detecting elevated inflammatory markers (CRP/ESR) and positive antinuclear antibodies (ANA) [5].

General principles of diagnosing systemic conditions

Diagnosing systemic diseases is often challenging due to the wide range of symptoms and their non-specificity. For example, in the case of cyclic vomiting syndrome, the average period between symptom onset and diagnosis in children was 2.3 years, indicating the difficulties in recognizing such conditions [6]. Systemic sclerosis is characterized by elevated inflammatory markers and the presence of autoantibodies [5]. In cases of rare neurocutaneous syndromes, such as Sturge-Weber syndrome, an interdisciplinary approach and consensus guidelines are required to evaluate and manage neurological and ophthalmological manifestations [4].

Some systemic conditions can mimic other diseases. For example, plasma cell leukemia, although not an autoimmune disease, can present with systemic symptoms such as dyspnea, weight loss, hemoptysis, and generalized hemorrhagic diathesis, as well as hepatosplenomegaly and congestive heart failure [1]. Diagnosis in such cases includes identifying anemia, thrombocytopenia, leukocytosis with circulating immature plasma cells, and increased serum viscosity [1].

Approaches to treatment of systemic diseases

Treatment of systemic autoimmune and other complex systemic conditions requires a personalized approach and often involves a combination of therapeutic methods:

• Immunosuppressive therapy: Mycophenolate mofetil may be used in systemic sclerosis [5].
• Symptomatic and supportive therapy: Rifaximin and hyoscine are used to alleviate gastrointestinal symptoms in SSc [5].
• Specialized methods: In some cases, more specific interventions are used. For example, in hyperviscosity syndrome associated with plasma cell leukemia, emergency plasmapheresis can significantly improve clinical manifestations [1]. Systemic chemotherapy is also a treatment method for plasma cell leukemia [1].
• Regenerative medicine: Mesenchymal stem cell therapy (MSC therapy) has been investigated in systemic sclerosis; however, it is important to consider potential risks and complications associated with such treatment, including the development of malignancies [8].
• Monitoring and screening: Patients with systemic sclerosis have an increased risk of developing malignancies, emphasizing the need for timely screening and awareness of potential risks associated with therapy [8].

It is important to note that while some sources mention novel techniques such as radiofrequency ablation for rosacea [2] or transcutaneous vagus nerve stimulation for heart failure [3], these approaches are not directly related to the treatment of systemic lupus erythematosus or systemic sclerosis, but they demonstrate the diversity of therapeutic strategies in modern medicine.

Conclusion

Systemic autoimmune diseases, such as systemic lupus erythematosus and systemic sclerosis, represent complex conditions requiring a deep understanding of their pathogenesis, careful diagnosis, and a multifaceted approach to treatment. Although the presented scientific articles do not focus directly on SLE, they emphasize the importance of early diagnosis, comprehensive therapy, and ongoing monitoring to improve the quality of life for patients with systemic diseases.

References

• 1. Plasma cell leukemia and hyperviscosity syndrome. (1990) https://pubmed.ncbi.nlm.nih.gov/2196691/
• 2. Sphenopalatine Ganglion Radiofrequency Ablation for Severe Facial Rosacea Manifestations. (2026) https://pubmed.ncbi.nlm.nih.gov/41918220/
• 3. The efficacy of transcutaneous vagus nerve stimulation in heart failure management - a systematic review and meta-analysis. (2025) https://pubmed.ncbi.nlm.nih.gov/40615792/
• 4. Consensus Statement for the Management and Treatment of Sturge-Weber Syndrome: Neurology, Neuroimaging, and Ophthalmology Recommendations. (2021) https://pubmed.ncbi.nlm.nih.gov/34153815/
• 5. Severe scleroderma colopathy at initial diagnosis of systemic sclerosis in a young man: a case report. (2026) https://pubmed.ncbi.nlm.nih.gov/41907233/
• 6. Cyclic vomiting syndrome. (2026) https://pubmed.ncbi.nlm.nih.gov/41719916/
• 7. Clinical decision-making in gastric taeniasis: risks of endoscopic removal and role of staged therapy. (2026) https://pubmed.ncbi.nlm.nih.gov/42014166/
• 8. A Complex Case of Systemic Sclerosis with Concurrent Breast Malignancy and Treatment-related Complications. (2026) https://pubmed.ncbi.nlm.nih.gov/42543979/

Disclaimer: The information provided in this article is for reference purposes only and is not intended for self-diagnosis or self-treatment. Always consult a qualified healthcare professional for an accurate diagnosis and individualized treatment plan.